Mice that are haploinsufficient for FAK expression show increased tumour growth and angiogenesis, indicating a dose‐dependent role for FAK 9, and this has raised the notion that homozygous FAK KD animals may show a different tumour angiogenic phenotype in vivo. The gene discussed is PTK2; the disease is neoplasm.